Skip to main content
. 2010 Dec 2;2(1):131–135. doi: 10.3892/etm.2010.169

Figure 2.

Figure 2.

Correlation between the 6-biomarker index score and the 5-year survival of melanoma patients. A high combined 6-biomarker index score was correlated with (A) more favorable overall 5-year patient survival, and (B) disease-specific 5-year survival (n=118; P<0.001 for both, log-rank test).